Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: A multicentre, randomised, double-blind, phase III trial

Mycoses

Volumn 53, Issue 6, 2010, Pages 522-529

  Yim, S M ^a   Ko, J H ^a   Lee, Y W ^a   Kim, H W ^b   Lee, J Y ^b   Kim, N I ^c   Kye, Y C ^d   Park, K C ^e   Choi, J H ^f   Lee, K H ^g   Kim, M N ^h   Kim, K J ⁱ   Ro, Y S ^j   Ahn, K J ^a  

^a Konkuk University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Seoul National University   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Chung Ang University College of Medicine   (South Korea)

ⁱ Hallym University College of Medicine   (South Korea)

^j Hanyang University College of Medicine   (South Korea)

more..

Author keywords

Fluconazole cream; Flutrimazole Cream; Randomised Controlled Trial; Superficial Mycosis

Indexed keywords

FLUCONAZOLE; FLUTRIMAZOLE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIFUNGAL ACTIVITY; ARTICLE; BLISTER; CLINICAL TRIAL; CONJUNCTIVITIS; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FACE EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMPETIGO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOFASCIAL PAIN; NAUSEA; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN ALLERGY; SMEAR; SUPERFICIAL MYCOSIS; TREATMENT OUTCOME; URTICARIA; VOMITING;

ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CLOTRIMAZOLE; DERMATOMYCOSES; DOUBLE-BLIND METHOD; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; SKIN; TREATMENT OUTCOME;

FUNGI;

EID: 77958085967     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01738.x     Document Type: Article

References (16)

1. Lyman CA, Walsh TJ. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs 1992; 44: 9-35.
2. Odds FC, Cheesman SL, Abbott AB. Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. J Antimicrob Chemother 1986; 18: 473-8.
3. Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazole. Antimicrob Agents Chemother 1998; 50: 1-8.
4. Zerovos M, Silverman J, Meunier F. Fluconazole in fungal infection: a review. Infect Dis Clin Pract 1994; 3: 94.
5. Bertram G, Katzung BG. Clinical Pharmacology, 7th edn. San Francisco: Appleton & Lange publishing Co., 1998 887-91.
6. Alomar A, Videla S, Delgadillo J et al. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group. Dermatology 1995; 190: 295-300.
7. Del Palacio A, Cuetara S, Izquierdo I. A double blind randomized comparative trial: flutrimazole 1% solution vs. bifonazole 1% solution once daily in dermatomycoses. Mycoses 1995; 38: 395-403.
8. Binet O, Soto-Melo J, Delgadillo J et al. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole Study Group. Mycoses 1994; 37: 455-9.
9. Del Palacio A, Cuetara S, Perez A et al. Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream. Mycoses 1999; 42: 649-55.
10. Hardman JG, Limbird LE, Molinoff PB et al. The Pharmacological Basis of Therapeutics (Goodman & Gilman's), 9th edn. New York, USA: McGraw-Hill, 1996 1180-4.
11. Califano L, Cannavo SP, Ghittoni S et al. Multicenter oper randomized comparative study on efficacy and safety of topical fluconazole 0.5% vs. econazole lipogel 1% in the treatment of localized dermatomycoses. G Ital Dermatol Venereol 1999; 134: 263-9.
12. Aste N, Baldar U, Bellini M et al. Efficacy and safety of the topical formulation of fluconazole 0.5% (gel containing an emulsion oil/water) in the treatment of dermatomycoses with localized lesions: results of a multicenter, open, non comparative study. G Ital Dermatol Venereol 1999; 134: 61-5.
13. Barbanoj MJ, Antonijoan R, Garcia-Gea C et al. Eberconazole cream: topical and general tolerability, sensitization potential, and systemic availability. Methods Find Exp Clin Pharmacol 2005; 27: 227-34.
14. Gupta AK, Skinner AR, Cooper EA. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Int J Dermatol 2005; 44: 590-3.
15. Singal A, Pandhi D, Agrawal S et al. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. J Dermatolog Treat 2005; 16: 331-5.
16. Smith EB. The treatment of dermatophytosis: safety considerations. J Am Acad Dermatol 2000; 43(Suppl. 5): 113-9.